1.
Langley RG, Crowley J, Gooderham M, Papp KA, Korman NJ, Spelman L, Igarashi A, Ohtsuki M, Gupta AK, Yamauchi P, Parno J, Mendelsohn AM, Rozzo SJ, Eads K. Efficacy and Safety of Long-Term Tildrakizumab for Plaque Psoriasis: 4-Year Results from Resurface 1 and Resurface 2. J of Skin [Internet]. 2020Sep.2 [cited 2022Jul.5];4(5):s39. Available from: https://www.jofskin.org/index.php/skin/article/view/988